infliximab
Ixifi, a Biosimilar of Remicade, Receives Approval
FDA approves another biosimilar of Remicade. Ixifi has all of the same indications.
DECEMBER 21, 2017
FDA Approves Second Biosimilar of Remicade
Renlexis, a TNF blocker, will be indicated for the treatment of adult and pediatric Crohn’s disease, adult ...
APRIL 26, 2017
Load more